Suppr超能文献

术前甲胎蛋白、总胆红素、纤维蛋白原、白蛋白和淋巴细胞可预测肝癌患者术后生存情况。

Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma.

机构信息

Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Branch of National Clinical Research Center for Laboratory Medicine, Nanjing, Jiangsu, China.

出版信息

Cancer Med. 2023 Jun;12(12):13319-13328. doi: 10.1002/cam4.6030. Epub 2023 May 8.

Abstract

AIMS

Our study focused on exploring the feasible prognostic laboratory parameters of HCC and establishing a score model to estimate individualized overall survival (OS) in HCC after resection.

METHODS

Four hundred and sixty-one patients with HCC who underwent hepatectomy between January 2010 and December 2017 was enrolled in this investigation. Cox proportional hazards model was conducted to analyze the prognostic value of laboratory parameters. The score model construction was based on the forest plot results. Overall survival was evaluated by Kaplan-Meier method and the log-rank test. The novel score model was validated in an external validation cohort from a different medical institution.

RESULTS

We identified that alpha fetoprotein (AFP), total bilirubin (TB), fibrinogen (FIB), albumin (ALB), and lymphocyte (LY) were independent prognostic factors. High AFP, TB, FIB (HR > 1, p < 0.05), and low ALB, LY (HR < 1, p < 0.05) were associated with the survival of HCC. The novel score model of OS based on these five independent prognostic factors achieved high C-index of 0.773 (95% confidence interval [CI]: 0.738-0.808), which was significantly higher than those of the single five independent factors (0.572-0.738). The score model was validated in the external cohort whose C-index was 0.7268 (95% CI: 0.6744-0.7792).

CONCLUSION

The novel score model we established was an easy-to-use tool which could enable individualized estimation of OS in patients with HCC who underwent curative hepatectomy.

摘要

目的

本研究旨在探讨肝癌(HCC)可行的预后实验室参数,并建立评分模型以估计 HCC 患者术后的个体化总生存(OS)。

方法

本研究纳入了 2010 年 1 月至 2017 年 12 月期间接受肝切除术的 461 例 HCC 患者。采用 Cox 比例风险模型分析实验室参数的预后价值。基于森林图结果构建评分模型。采用 Kaplan-Meier 法和对数秩检验评估总生存。在来自不同医疗机构的外部验证队列中验证了新的评分模型。

结果

我们确定甲胎蛋白(AFP)、总胆红素(TB)、纤维蛋白原(FIB)、白蛋白(ALB)和淋巴细胞(LY)是独立的预后因素。高 AFP、TB、FIB(HR>1,p<0.05)和低 ALB、LY(HR<1,p<0.05)与 HCC 的生存相关。基于这五个独立预后因素的 OS 新评分模型的 C 指数为 0.773(95%置信区间 [CI]:0.738-0.808),明显高于五个独立因素的 C 指数(0.572-0.738)。该评分模型在外部队列中得到验证,其 C 指数为 0.7268(95%CI:0.6744-0.7792)。

结论

我们建立的新评分模型是一种易于使用的工具,可以对接受根治性肝切除术的 HCC 患者的 OS 进行个体化估计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5718/10315827/525b8a1b902c/CAM4-12-13319-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验